Aurinia Pharmaceuticals announced that it will present positive data from its Phase 2b clinical trial evaluating the efficacy and safety…
Articles by Ines Martins, PhD
The Lupus Foundation of America (LFA)  recently honored Richard A. Rosenbaum, the executive chairman of the law firm Greenberg Traurig, with the…
The Lupus Research Alliance recently launched a new initiative called the Lupus Clinical Investigators Network (LuCIN) to accelerate the…
Researchers have found that a group of proteins in wheat may be responsible for triggering inflammation in chronic conditions such as…
Researchers identified 23 genes associated with a predisposition for vitiligo, an autoimmune disease characterized by patches of skin and hair that…
Singer Lori Jenaire is on a mission beyond sales and charting. With the release of her single — which listed…
Kevin J. Tracey, MD, CEO and president of The Feinstein Institute for Medical Research, is the winner of the Frederik B. Bang…
Aurinia Pharmaceuticals announced that seven of the 10 patients with lupus nephritis (LN) enrolled in its AURION study, evaluating short-term predictors…
Researchers at Temple University Hospital are taking part in a large, global Phase 3 clinical trial to evaluate whether a novel, investigational drug for…
Aurinia Pharmaceuticals announced that its AURA-LV clinical trial, assessing voclosporin for the treatment of lupus nephritis (LN), has achieved its primary endpoint…